Skip to main content
logo
Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
0.3766
-0.0120 (-3.09%)
At close: Jun 5, 2026, 4:00 PM EDT
0.3780
+0.0014 (0.37%)
After-hours: Jun 5, 2026, 7:29 PM EDT

Immutep Revenue

Immutep had revenue of 4.10M AUD in the half year ending December 31, 2025, with 4,506.79% growth. This brings the company's revenue in the last twelve months to 51.77K, down -2.90% year-over-year. In the fiscal year ending June 30, 2025, Immutep had annual revenue of 59.71K, down -49.86%.

Revenue (ttm)
51.77K AUD
Revenue Growth
-2.90%
P/S Ratio
9.47
Revenue / Employee
1,670 AUD
Employees
31
Market Cap
50.02M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202559.71K-59.38K-49.86%
Jun 30, 2024119.09K-72.63K-37.88%
Jun 30, 2023191.72K-62.67K-24.63%
Jun 30, 2022254.39K-58.45K-18.68%
Jun 30, 2021312.84K-7.45M-95.97%
Jun 30, 20207.77M6.47M499.78%
Jun 30, 20191.29M-2.34M-64.42%
Jun 30, 20183.64M2.84M354.63%
Jun 30, 2017800.46K625.41K357.27%
Jun 30, 2016175.05K--
Jun 30, 2015---
Jun 30, 2014---
Jun 30, 2013---
Jun 30, 2012---
Jun 30, 2011---
Jun 30, 2010---
Jun 30, 2009---
Jun 30, 2008---
Jun 30, 2007---
Jun 30, 2006---
Jun 30, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Xilio Therapeutics53.48M
Metagenomi Therapeutics22.33M
Veru Inc.16.89M
Radiopharm Theranostics10.86M
Mereo BioPharma Group500.00K
aTyr Pharma190.00K
Revenue Rankings

IMMP News

More News